Effect of 1 25-dihydroxyvitamin D3 Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons

STATUS

Not Recruiting
participants needed

75
sponsor

Mayo Clinic

Send

Updated on 19 February 2024

See if I qualify

body mass index

insulin

fasting

serum glucose

prediabetic state

Summary

The aim of this study is to assess the effects of 1,25(OH)2D3 on insulin secretion by the pancreas and glucose utilization by skeletal muscle as well as to determine the effects of 1,25(OH)2D3 on muscle strength in pre-diabetic persons

Details

Condition	Prediabetes
Age	20-45 years
Treatment	Oral Placebo, Calcitriol capsules
Clinical Study Identifier	NCT04286529
Sponsor	Mayo Clinic
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	b'Body mass index (BMI) of >24kg/m2'
	b'Fasting serum glucose <126 mg/dL'
Exclusion Criteria
	b'BMI</=24 kg/m2'
	b'Fasting serum glucose >/=126 mg/dL'
	b'Patient is taking Calcium or Vitamin D supplements and is unwilling to stop for 8'
	b'weeks'
	b'Serum Calcium >10.2 mg/dL'
	b'Serum inorganic phosphorous >4.5mg/dL'
	b'Pregnancy or breastfeeding'
	b'Diagnosis of Diabetes Mellitus'
	b'Diagnosis of Rheumatoid Arthritis'
	b'Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)'
	b'Renal in sufficiency/failure ( serum creatinine >1.5 mg/dL men, > 1.3 mg/dL women)'
	b'Chronic active liver disease (bilirubin >1.2 mg/dL, AST>144IU/L, or ALT >165 IU/L)'
	b'History of chronic hepatitis'
	b'Active coronary artery disease ( unstable angina, myocardial infarction, stroke and'
	b'revascularization of coronary, peripheral or carotid artery within the last 3 months)'
	b'Oral warfarin group medications or history of blood clotting disorders'
	b'Platelet count <100,000 per uL within the last 7 days'
	b'Alcohol consumption greater than 2 glasses/day or other substance abuse'
	b'Untreated or uncontrolled thyroid disorders (outside a TSH range of 0.5 to 10mIU/L)'
	b'Debilitating chronic disease (at the discretion of the investigators)'
	b'The presence of infections, highly communicable diseases ( AIDS, active tuberculosis,'
	b'venereal disease, hepatitis)'
	b'Any malignancy'

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Study Definition

Wikipedia

Effect of 1 25-dihydroxyvitamin D3 Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons